HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. 1998

R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos

UI MeSH Term Description Entries
D008297 Male Males
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016263 AIDS-Associated Nephropathy Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients. HIV-Associated Nephropathy,Human Immunodeficiency Virus-Associated Nephropathy,AIDS Nephropathy,AIDS-Associated Nephropathies,HIV-Associated Nephropathies,HIV-Related Nephropathies,HIV-Related Nephropathy,Nephropathies, AIDS-Associated,Nephropathies, HIV-Associated,Nephropathies, HIV-Related,Nephropathy, AIDS-Associated,Nephropathy, HIV-Associated,Nephropathy, HIV-Related,AIDS Associated Nephropathies,AIDS Associated Nephropathy,AIDS Nephropathies,HIV Associated Nephropathies,HIV Associated Nephropathy,HIV Related Nephropathies,HIV Related Nephropathy,Human Immunodeficiency Virus Associated Nephropathy,Nephropathies, AIDS,Nephropathies, AIDS Associated,Nephropathies, HIV Associated,Nephropathies, HIV Related,Nephropathy, AIDS,Nephropathy, AIDS Associated,Nephropathy, HIV Associated,Nephropathy, HIV Related
D018119 Stavudine A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. 2',3'-Didehydro-3'-deoxythymidine,D4T,2',3'-Didehydro-2',3'-dideoxythmidine,BMY-27857,Stavudine, Monosodium Salt,Zerit,2',3' Didehydro 3' deoxythymidine,BMY 27857,BMY27857
D019259 Lamivudine A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. 2',3'-Dideoxy-3'-thiacytidine,2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-,3TC Lamivudine,Lamivudine, (+)-cis-,Lamivudine, (+-)-trans-,BCH-189,Epivir,GR-109714X,GR109714X,Lamivudine, (2S-cis)-Isomer,2',3' Dideoxy 3' thiacytidine,BCH 189,BCH189,GR 109714X,Lamivudine, 3TC

Related Publications

R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
May 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
January 2007, AIDS (London, England),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
November 1998, Lancet (London, England),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
February 2004, AIDS (London, England),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
May 2002, AIDS (London, England),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
July 2007, Journal of acquired immune deficiency syndromes (1999),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
November 2001, AIDS (London, England),
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
December 2009, Movement disorders : official journal of the Movement Disorder Society,
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
May 2001, The Journal of infection,
R K Wali, and C I Drachenberg, and J C Papadimitriou, and S Keay, and E Ramos
January 2006, Mental retardation and developmental disabilities research reviews,
Copied contents to your clipboard!